Singapore: Sino-Singapore Healthcare Fund raises US$150m

From Left to Right: Terence Loh, CEO and co-founder, Novena Global Lifecare Nelson Loh, executive chairman and co-founder, Novena Global Lifecare Wu Aimin, president, Sinopharm Capital and Dai Songsong, managing partner, Cedarlake Capital

Private equity firms Sinopharm Capital and Cedarlake Capital Group have come together with Singapore-based Novena Global Lifecare Group to create the US$150m Sino-Singapore Healthcare Fund. The fund will invest in medical services, biomedical projects, mature drugs, and precision medicine. At the same time, the two private equity firms have invested US$20m in Novena Global. “Sinopharm…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »